• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition.κ-阿片受体在多巴胺神经元中的激活会破坏行为抑制。
Neuropsychopharmacology. 2018 Jan;43(2):362-372. doi: 10.1038/npp.2017.133. Epub 2017 Jun 26.
2
Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.κ阿片受体诱导的厌恶反应需要腹侧被盖区多巴胺能神经元中的p38丝裂原活化蛋白激酶激活。
J Neurosci. 2015 Sep 16;35(37):12917-31. doi: 10.1523/JNEUROSCI.2444-15.2015.
3
Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking.背缝核内κ阿片受体的激活介导应激的厌恶效应,并重新引发药物寻求。
Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19168-73. doi: 10.1073/pnas.0910705106. Epub 2009 Oct 28.
4
Kappa-opioid agonists directly inhibit midbrain dopaminergic neurons.κ-阿片受体激动剂直接抑制中脑多巴胺能神经元。
J Neurosci. 2003 Nov 5;23(31):9981-6. doi: 10.1523/JNEUROSCI.23-31-09981.2003.
5
Regulation of Kappa Opioid Receptor Inactivation Depends on Sex and Cellular Site of Antagonist Action.κ 阿片受体失活的调节依赖于性别和拮抗剂作用的细胞部位。
Mol Pharmacol. 2020 Nov;98(5):548-558. doi: 10.1124/molpharm.120.000124. Epub 2020 Sep 10.
6
Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.纳呋拉啡是一种G蛋白偏向性激动剂,在人κ阿片受体上的偏向性显著大于在啮齿动物κ阿片受体上的偏向性。
Cell Signal. 2017 Apr;32:59-65. doi: 10.1016/j.cellsig.2017.01.016. Epub 2017 Jan 11.
7
Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes.在神经元和星形胶质细胞中,κ阿片受体对p38丝裂原活化蛋白激酶的激活是依赖于G蛋白偶联受体激酶3(GRK3)和抑制蛋白的。
J Biol Chem. 2006 Jun 30;281(26):18081-9. doi: 10.1074/jbc.M513640200. Epub 2006 Apr 28.
8
Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.雌激素对 GRK2 的调节使κ阿片受体信号失活,介导镇痛,但不介导厌恶。
J Neurosci. 2018 Sep 12;38(37):8031-8043. doi: 10.1523/JNEUROSCI.0653-18.2018. Epub 2018 Aug 3.
9
Stress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.应激诱导的尼古丁偏好恢复需要基底外侧杏仁核中的强啡肽/κ阿片样物质活性。
J Neurosci. 2016 Sep 21;36(38):9937-48. doi: 10.1523/JNEUROSCI.0953-16.2016.
10
Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake.应激通过在腹侧纹状体释放内源性强啡肽来产生厌恶感并增强可卡因的奖赏效应,从而局部刺激 5-羟色胺再摄取。
J Neurosci. 2012 Dec 5;32(49):17582-96. doi: 10.1523/JNEUROSCI.3220-12.2012.

引用本文的文献

1
An integrated microfluidic and fluorescence platform for probing in vivo neuropharmacology.一种用于探究体内神经药理学的集成微流控与荧光平台。
Neuron. 2025 May 21;113(10):1491-1506.e6. doi: 10.1016/j.neuron.2025.03.017. Epub 2025 Apr 10.
2
Dezocine modulates the reinstatement of conditioned place preference in morphine-dependent rats via the dopamine reward circuitry.地佐辛通过多巴胺奖赏回路调节吗啡依赖大鼠条件性位置偏爱行为的恢复。
Front Neurosci. 2025 Feb 18;19:1507747. doi: 10.3389/fnins.2025.1507747. eCollection 2025.
3
Limitations and potential of κOR biased agonists for pain and itch management.κ 阿片受体偏向性激动剂在疼痛和瘙痒管理中的局限性和潜力。
Neuropharmacology. 2024 Nov 1;258:110061. doi: 10.1016/j.neuropharm.2024.110061. Epub 2024 Jul 2.
4
Endogenous Opioids in the Homeostatic Regulation of Hunger, Satiety, and Hedonic Eating: Neurobiological Foundations.内源性阿片肽在饥饿、饱腹感和享乐性进食的稳态调节中的作用:神经生物学基础。
Adv Neurobiol. 2024;35:315-327. doi: 10.1007/978-3-031-45493-6_16.
5
A Combination of a Dopamine Receptor 2 Agonist and a Kappa Opioid Receptor Antagonist Synergistically Reduces Weight in Diet-Induced Obese Rodents.一种多巴胺受体 2 激动剂和 κ 阿片受体拮抗剂的联合使用可协同减轻饮食诱导肥胖啮齿动物的体重。
Nutrients. 2024 Jan 31;16(3):424. doi: 10.3390/nu16030424.
6
Kappa Opioid Receptors Reduce Serotonin Uptake and Escitalopram Efficacy in the Mouse Substantia Nigra Pars Reticulata.κ 阿片受体减少小鼠黑质网状部 5-羟色胺摄取和依他普仑的疗效。
Int J Mol Sci. 2023 Jan 20;24(3):2080. doi: 10.3390/ijms24032080.
7
Optogenetic stimulation of dynorphinergic neurons within the dorsal raphe activate kappa opioid receptors in the ventral tegmental area and ablation of dorsal raphe prodynorphin or kappa receptors in dopamine neurons blocks stress potentiation of cocaine reward.对中缝背核内强啡肽能神经元进行光遗传学刺激可激活腹侧被盖区的κ阿片受体,而多巴胺能神经元中中缝背核前强啡肽或κ受体的缺失会阻断应激对可卡因奖赏的增强作用。
Addict Neurosci. 2022 Mar;1. doi: 10.1016/j.addicn.2022.100005. Epub 2022 Jan 25.
8
Traumatic Stress-Induced Vulnerability to Addiction: Critical Role of the Dynorphin/Kappa Opioid Receptor System.创伤应激导致的成瘾易感性:强啡肽/κ阿片受体系统的关键作用。
Front Pharmacol. 2022 Apr 27;13:856672. doi: 10.3389/fphar.2022.856672. eCollection 2022.
9
Quantitative Systems Pharmacology and Biased Agonism at Opioid Receptors: A Potential Avenue for Improved Analgesics.定量系统药理学与阿片受体的偏性激动作用:改善镇痛药的潜在途径。
Int J Mol Sci. 2022 May 4;23(9):5114. doi: 10.3390/ijms23095114.
10
Comparative effects of cannabinoid CB1 receptor agonist and antagonist on timing impulsivity induced by d-amphetamine in a differential reinforcement of low-rate response task in male rats.大麻素 CB1 受体激动剂和拮抗剂对雄性大鼠在低反应率强化任务中 d-amphetamine 诱导的时间冲动性的比较影响。
Psychopharmacology (Berl). 2022 May;239(5):1459-1473. doi: 10.1007/s00213-021-06018-z. Epub 2021 Nov 6.

本文引用的文献

1
Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.纳呋拉啡是一种G蛋白偏向性激动剂,在人κ阿片受体上的偏向性显著大于在啮齿动物κ阿片受体上的偏向性。
Cell Signal. 2017 Apr;32:59-65. doi: 10.1016/j.cellsig.2017.01.016. Epub 2017 Jan 11.
2
Midbrain dopamine neurons signal aversion in a reward-context-dependent manner.中脑多巴胺神经元以奖赏背景依赖的方式发出厌恶信号。
Elife. 2016 Oct 19;5:e17328. doi: 10.7554/eLife.17328.
3
Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction.κ阿片受体功能的性别差异及其对成瘾的潜在影响。
Front Neurosci. 2015 Dec 16;9:466. doi: 10.3389/fnins.2015.00466. eCollection 2015.
4
Supersensitive Kappa Opioid Receptors Promotes Ethanol Withdrawal-Related Behaviors and Reduce Dopamine Signaling in the Nucleus Accumbens.超敏κ阿片受体促进乙醇戒断相关行为并降低伏隔核中的多巴胺信号传导。
Int J Neuropsychopharmacol. 2016 Apr 29;19(5). doi: 10.1093/ijnp/pyv127. Print 2016 May.
5
Sufficiency of Mesolimbic Dopamine Neuron Stimulation for the Progression to Addiction.中脑边缘多巴胺神经元刺激足以导致成瘾。
Neuron. 2015 Dec 2;88(5):1054-1066. doi: 10.1016/j.neuron.2015.10.017. Epub 2015 Nov 12.
6
Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.κ阿片受体诱导的厌恶反应需要腹侧被盖区多巴胺能神经元中的p38丝裂原活化蛋白激酶激活。
J Neurosci. 2015 Sep 16;35(37):12917-31. doi: 10.1523/JNEUROSCI.2444-15.2015.
7
Endogenous Opioid Signaling in the Medial Prefrontal Cortex is Required for the Expression of Hunger-Induced Impulsive Action.饥饿诱导的冲动行为的表达需要内侧前额叶皮质中的内源性阿片信号传导。
Neuropsychopharmacology. 2015 Sep;40(10):2464-74. doi: 10.1038/npp.2015.97. Epub 2015 Apr 13.
8
Importance of sex differences in impulse control and addictions.冲动控制与成瘾中性别差异的重要性。
Front Psychiatry. 2015 Feb 18;6:24. doi: 10.3389/fpsyt.2015.00024. eCollection 2015.
9
Kappa opioid receptor activation potentiates the cocaine-induced increase in evoked dopamine release recorded in vivo in the mouse nucleus accumbens.κ阿片受体激活增强了可卡因诱导的、在小鼠伏隔核体内记录到的诱发多巴胺释放增加。
Neuropsychopharmacology. 2014 Dec;39(13):3036-48. doi: 10.1038/npp.2014.157. Epub 2014 Jun 27.
10
Stress and VTA synapses: implications for addiction and depression.应激与腹侧被盖区突触:对成瘾和抑郁的影响
Eur J Neurosci. 2014 Apr;39(7):1179-88. doi: 10.1111/ejn.12490.

κ-阿片受体在多巴胺神经元中的激活会破坏行为抑制。

κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition.

机构信息

Department of Pharmacology, University of Washington School of Medicine, Seattle, WA, USA.

Research Center of the Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montreal, Quebec, Canada.

出版信息

Neuropsychopharmacology. 2018 Jan;43(2):362-372. doi: 10.1038/npp.2017.133. Epub 2017 Jun 26.

DOI:10.1038/npp.2017.133
PMID:28649993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5729556/
Abstract

The dynorphin/κ-opioid receptor (KOR) system has been previously implicated in the regulation of cognition, but the neural circuitry and molecular mechanisms underlying KOR-mediated cognitive disruption are unknown. Here, we used an operational test of cognition involving timing and behavioral inhibition and found that systemic KOR activation impairs performance of male and female C57BL/6 mice in the differential reinforcement of low response rate (DRL) task. Systemic KOR antagonism also blocked stress-induced disruptions of DRL performance. KOR activation increased 'bursts' of incorrect responses in the DRL task and increased marble burying, suggesting that the observed disruptions in DRL performance may be attributed to KOR-induced increases in compulsive behavior. Local inactivation of KOR by injection of the long-acting antagonist nor-BNI in the ventral tegmental area (VTA), but not the infralimbic prefrontal cortex (PFC) or dorsal raphe nucleus (DRN), prevented disruption of DRL performance caused by systemic KOR activation. Cre-dependent genetic excision of KOR from dopaminergic, but not serotonergic neurons, also blocked KOR-mediated disruption of DRL performance. At the molecular level, we found that these disruptive effects did not require arrestin-dependent signaling, because neither global deletion of G-protein receptor kinase 3 (GRK3) nor cell-specific deletion of GRK3/arrestin-dependent p38α MAPK from dopamine neurons blocked KOR-mediated DRL disruptions. We then showed that nalfurafine, a clinically available G-biased KOR agonist, could also produce DRL disruptions. Together, these studies demonstrate that KOR activation in VTA dopamine neurons disrupts behavioral inhibition in a GRK3/arrestin-independent manner and suggests that KOR antagonists could be beneficial for decreasing stress-induced compulsive behaviors.

摘要

阿片肽/κ 型受体(KOR)系统以前被认为参与调节认知,但 KOR 介导的认知障碍的神经回路和分子机制尚不清楚。在这里,我们使用了一种涉及计时和行为抑制的认知操作测试,发现全身 KOR 激活会损害雄性和雌性 C57BL/6 小鼠在差异强化低反应率(DRL)任务中的表现。全身 KOR 拮抗作用也阻断了应激引起的 DRL 表现障碍。KOR 激活增加了 DRL 任务中的错误反应“爆发”,并增加了大理石掩埋,这表明观察到的 DRL 表现障碍可能归因于 KOR 诱导的强迫行为增加。通过向腹侧被盖区(VTA)注射长效拮抗剂 nor-BNI 局部失活 KOR,而不是向边缘前皮质(PFC)或中缝核(DRN)注射,可防止全身 KOR 激活引起的 DRL 表现障碍。Cre 依赖性基因敲除 KOR 从多巴胺能神经元,但不是 5-羟色胺能神经元,也阻止了 KOR 介导的 DRL 表现障碍。在分子水平上,我们发现这些破坏作用不需要依赖 arrestin 的信号转导,因为全局敲除 G 蛋白受体激酶 3(GRK3)或多巴胺神经元中特异性敲除 GRK3/arrestin 依赖性 p38α MAPK 均不能阻断 KOR 介导的 DRL 破坏。然后,我们表明,纳呋拉啡,一种临床可用的 G 偏倚 KOR 激动剂,也可以产生 DRL 破坏。总之,这些研究表明,VTA 多巴胺神经元中的 KOR 激活以 GRK3/arrestin 独立的方式破坏行为抑制,并表明 KOR 拮抗剂可能有助于减少应激诱导的强迫行为。